Y
Yingjiang Ye
Researcher at Peking University
Publications - 229
Citations - 4721
Yingjiang Ye is an academic researcher from Peking University. The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 29, co-authored 192 publications receiving 3047 citations. Previous affiliations of Yingjiang Ye include Peking Union Medical College & Dalian Medical University.
Papers
More filters
Journal ArticleDOI
Lineage tracking reveals dynamic relationships of T cells in colorectal cancer.
Lei Zhang,Xin Yu,Liangtao Zheng,Yuanyuan Zhang,Yansen Li,Qiao Fang,Ranran Gao,Boxi Kang,Qiming Zhang,Julie Y. Huang,Hiroyasu Konno,Guo Xinyi,Yingjiang Ye,Songyuan Gao,Shan Wang,Xueda Hu,Xianwen Ren,Zhanlong Shen,Wenjun Ouyang,Zemin Zhang +19 more
TL;DR: An integrated RNA-sequencing approach demonstrates that CXCL13+ TH1-like cells are preferentially enriched in microsatellite-instable tumours from patients with colorectal cancer, and IGFLR1 is identified as a co-stimulatory molecule.
Journal ArticleDOI
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer.
Lei Zhang,Ziyi Li,Katarzyna M. Skrzypczynska,Qiao Fang,Wei Zhang,Sarah A. O’Brien,Yao He,Lynn Wang,Qiming Zhang,Aeryon Kim,Ranran Gao,Jessica Orf,Tao Wang,Deepali V. Sawant,Jiajinlong Kang,Dev Bhatt,Daniel Lu,Chi-Ming Li,Aaron S. Rapaport,Kristy Perez,Yingjiang Ye,Shan Wang,Xueda Hu,Xianwen Ren,Wenjun Ouyang,Zhanlong Shen,Jackson G. Egen,Zemin Zhang,Xin Yu +28 more
TL;DR: This comprehensive analysis of key myeloid subsets in human and mouse identifies critical cellular interactions regulating tumor immunity and defines mechanisms underlying myeloids-targeted immunotherapies currently undergoing clinical testing.
Journal ArticleDOI
Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients
TL;DR: Postoperative supplementation of omega-3 fatty acids may have a favorable effect on the outcomes in colorectal cancer patients undergoing radical resection by lowering the magnitude of inflammatory responses and modulating the immune response.
Journal ArticleDOI
Safety, quality and effect of complete mesocolic excision vs non‐complete mesocolic excision in patients with colon cancer: a systemic review and meta‐analysis
Chang Wang,Zhidong Gao,Kai Shen,Zhanlong Shen,Kewei Jiang,Bin Liang,Mujun Yin,Xin Yang,Suxia Wang,Yingjiang Ye +9 more
TL;DR: A meta‐analysis was performed to compare the safety, quality and effect of CME with non‐complete mesocolic excision (NCME) in patients with colon cancer.
Journal ArticleDOI
[Corrigendum] MicroRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
Yujun Zhang,Xiang-jun He,Yulan Liu,Yingjiang Ye,Hui Zhang,Peiying He,Qi Zhang,Ling-yi Dong,Yu-jing Liu,Jianqiang Dong +9 more
TL;DR: It is suggested that miR-320a may be a novel therapeutic candidate for the treatment of colorectal cancer and useful for identifying CRC patients that are at an elevated risk for developing liver metastasis.